cGxP.wire https://validator.w3.org/feed/docs/rss2.html Adagio Medical Advances vCLAS Ultra in Ventricular Tachycardia Insilico Opens AI Toolkit for Global Longevity Research Inductive Bio Launches Beacon-2 for AI Drug Discovery Insilico Medicine Advances AI-Designed BTK Cancer Drugs Aethlon Medical Merges With North Immunology for NOR-101 DarioHealth Expands AI Care to 1.5 Million Lives Nuvation Bio IBTROZI Label Updated With Long-Term Data Novo Nordisk Denecimig Shows Tolerability in Hemophilia A Akeso AK158D1 Gets NMPA Phase I Clearance for Tumors Roche Lunsumio Regimen Improves PFS in Follicular Lymphoma Bayer Kerendia Wins FDA Approval for Type 1 Diabetes CKD Teva Launches LongActingImpact.com for Schizophrenia Care Sling Therapeutics Starts Phase 3 Trial of Linsitinib The Braff Group Advises CCR on PhaseWell Partnership Eirion Therapeutics Reports First-in-Human ET-02 Data Lunai Bioworks Advances AI Chemical Risk Screening Dualitas Therapeutics and Roche Launch $1B Bispecific Collaboration Fennec Pharmaceuticals Presents Two-Year Pedmark Data in Japan Bristol Myers Squibb Reports Durable Sotyktu Results in PsA Orbis Medicines and Novo Nordisk Form $1.4B Discovery Deal Synergy Spine Solutions Reports Two-Year Synergy Disc Outcomes Aquestive Resubmits Anaphylm NDA to FDA Kamada Confirms KedRAB Supply Amid Rising U.S. Rabies Demand Nabsys Electronic Genome Mapping Advances Cancer Analysis OncoC4 Receives FDA Fast Track for Cesalatamig Viatris WAKIX Approved in Japan for Sleep Disorders MitoRx to Present MTRX31 Obesity Data at EASD 2026 Nona Biosciences Develops AI Model for Human Antibodies Sunshine Biopharma Advances PLpro Inhibitor Toward IND Curi Bio Advances FDA ISTAND Qualification for BoNT Assay SMSbiotech Advances COPD Program With FDA IND Clearance Aptitude Metrix COVID Test Receives FDA 510(k) Clearance A2 Biotherapeutics Advances A2B395 in Solid Tumors Gilead and PAHO Expand Lenacapavir HIV Prevention Access Merz Therapeutics Gains EU Approval for XEOMIN in Pediatric Spasticity DifGen Pharmaceuticals Wins FDA Approval for Epinephrine Genentech Advances Lunsumio in Phase III Follicular Lymphoma Boehringer Ingelheim Launches PED Essentials for Patient Evidence SNIPR Advances SNIPR001 Into Phase 2 for E. coli Prevention SetPoint Medical Expands RA Neuroimmune Therapy in Oregon IASO Bio IASO208 Receives FDA IND Clearance Galderma Advances Restylane Volyme in Chinese Temple Hollowing Chemify Raises £22M to Scale AI-Driven Chemistry Circle Pharma Raises $92.5M to Advance CID-165 Twist Bioscience Joins Lilly TuneLab for Antibody Discovery Eisai, Biogen LEQEMBI Pen Approved in Japan for Alzheimer’s Lundbeck Vyepti Receives Japan Approval for Migraine Prevention Cambium Bio Advances Elate Ocular Into Phase 3 Vera Therapeutics TRUTAKNA Shows Two-Year Kidney Benefit Novo Nordisk to Share New Cardiometabolic Data at EASD 2026!